Evidence map›Paper›PMID 35307410›Full record

ArticleThe Journal of infection2022

Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants.

Chloé Dimeglio, Jean-Michel Loubes, Marion Migueres, Karine Sauné, Pauline Trémeaux, Sébastien Lhomme, Noémie Ranger, Justine Latour, Jean-Michel Mansuy, Jacques Izopet

Abstract readLetter
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Chloé DimeglioINSERM UMR1291 - CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France; CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 France. Electronic address: dimeglio.c@chu-toulouse.fr.
Jean-Michel LoubesUniversité de Toulouse, Institut de Mathématiques de Toulouse, Toulouse 31400, France.
Marion MigueresINSERM UMR1291 - CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France; CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 France.
Karine SaunéINSERM UMR1291 - CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France; CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 France.
Pauline TrémeauxINSERM UMR1291 - CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France; CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 France.
Sébastien LhommeINSERM UMR1291 - CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France; CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 France.
Noémie RangerCHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 France.
Justine LatourCHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 France.
Jean-Michel MansuyCHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 France.
Jacques IzopetINSERM UMR1291 - CNRS UMR5051, Toulouse Institute for Infectious and Inflammatory Diseases (INFINITy), 31300 Toulouse, France; CHU Toulouse, Hôpital Purpan, Virology Laboratory, 31300 France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2HumansVaccinationOmicronPublic healthSARS-CoV-2Statistical model

Identifiers

PMID35307410
PMCPMC8926943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.